Sun Pharma

News

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

BY PTI

News

Sensex, Nifty Erase Intraday Gains, End on A Subdued Note; Reliance Falls A Day Ahead Of Earnings

BY Outlook Business Desk

News

Aurobindo, Sun Pharma Recall Products In US Market

BY PTI

Total revenue from operations rose to Rs 9,863 crore in the third quarter.

News

Sun Pharma Net Profit Up 11% At Rs 2,059 Crore In December Quarter

BY PTI

US is the worlds largest market of medicines

News

Sun Pharma, Lupin Recall Products In US market

BY PTI

India’s Best Fund Managers 2021

Driven by diligence

BY Anishaa Kumar

Trend

When the sun shines

BY Shailaja Mohapatra

Lead Story

When Wind Met Sun

BY Krishna Gopalan

Feature

What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?

BY Himanshu Kakkar

Lead Story

New growth model

BY Kripa Mahalingam

Editor's Note

Tricky Transition

BY N. Mahalakshmi

Feature

The Eclipse of A Star

BY Prathamesh Mulye

Perspective

Content Farming

BY N. Mahalakshmi

Feature

Seeking a Safe Haven

BY Prathamesh Mulye

State of the Economy 2019

Uphill Climb

BY Himanshu Kakkar

Feature

Ray of Hope

BY Khushboo Balani

Perspective

Hi Flipkart! I’m Walmart

BY N. Mahalakshmi

India's Best Fund Managers 2018

Opportunistic Buyer

BY Khushboo Balani

Graphically Speaking

Homesick

BY OLM Desk

Trend

Nursing Back to Health

BY Jash Kriplani

Lead Story

Under The Weather - Part 2

BY Krishna Gopalan

Lead Story

Under The Weather- Part 1

BY Krishna Gopalan

My Best Pick 2017

Niraj Dalal

BY OLM Desk

The Big Story

Transaction Initiated

BY Jash Kriplani

India's Best Fund Managers

Hitting Bullseye

BY V Keshavdev

Feature

One giant leap for Mankind

BY Himanshu Kakkar

Fastest Growing Companies 2015

Fastest Growing Companies 2015 - list 3

BY OLM Desk

Fastest Growing Companies 2015

Growth eclipse

BY Krishna Gopalan

Feature

If you've got it, <br> flaunt it </br>

BY Himanshu Kakkar

The Boss

Dilip Shanghvi

BY Krishna Gopalan

My Best Pick 2015

Manish Bhandari

BY OLM Desk

Lead Story

Critical condition

BY Kripa Mahalingam

load more stories

Sun Pharma

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

Sensex, Nifty Erase Intraday Gains, End on A Subdued Note; Reliance Falls A Day Ahead Of Earnings

Aurobindo, Sun Pharma Recall Products In US Market

Sun Pharma Net Profit Up 11% At Rs 2,059 Crore In December Quarter

Sun Pharma, Lupin Recall Products In US market

Driven by diligence

When the sun shines

Advertisement

When Wind Met Sun

What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?

New growth model

Tricky Transition

The Eclipse of A Star

Content Farming

Seeking a Safe Haven

Advertisement

Uphill Climb

Ray of Hope

Hi Flipkart! I’m Walmart

Opportunistic Buyer

Homesick

Nursing Back to Health

Under The Weather - Part 2

Advertisement

Under The Weather- Part 1

Niraj Dalal

Transaction Initiated

Hitting Bullseye

One giant leap for Mankind

Fastest Growing Companies 2015 - list 3

Growth eclipse

Advertisement

If you've got it, <br> flaunt it </br>

Dilip Shanghvi

Manish Bhandari

Critical condition